ESOMEPRAZOL IN TREATMENT OF GASTROESOPHAGIAL REFLUX DISEASE IN CHILDREN AND ADOLESCENTS

The results of trials of activity of esomeprazol in children with gastroesophagial reflux disease (gerd) are presented in this article. It was marked that esomeprazol (Nexium) can be used in children of 1–11 years (10 or 20 mg daily) and 12–17 years (20 or 40 mg daily) with gerd according to modern...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй
Үндсэн зохиолч: R.T. Saygitov
Формат: Өгүүллэг
Хэл сонгох:English
Хэвлэсэн: "Paediatrician" Publishers LLC 2008-08-01
Цуврал:Вопросы современной педиатрии
Онлайн хандалт:https://vsp.spr-journal.ru/jour/article/view/1441